$CRTG
CORETEC GROUP INC.

2024 Q3 Form 10-Q Financial Statement

#000143774924026718 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $234.8K
YoY Change -23.23%
% of Gross Profit
Research & Development $59.80K
YoY Change -50.76%
% of Gross Profit
Depreciation & Amortization $24.61K
YoY Change 6.81%
% of Gross Profit
Operating Expenses $59.80K
YoY Change -50.76%
Operating Profit
YoY Change
Interest Expense $39.78K
YoY Change -24.73%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$334.2K
YoY Change -29.53%
Income Tax
% Of Pretax Income
Net Earnings -$334.2K
YoY Change -29.53%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 336.7M 315.0M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.440K
YoY Change -99.69%
Cash & Equivalents $4.437K
Short-Term Investments
Other Short-Term Assets $285.3K
YoY Change 806.16%
Inventory
Prepaid Expenses $35.26K
Receivables
Other Receivables
Total Short-Term Assets $289.7K
YoY Change -80.45%
LONG-TERM ASSETS
Property, Plant & Equipment $101.8K
YoY Change -7.49%
Goodwill $166.0K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.550K
YoY Change 0.0%
Total Long-Term Assets $1.055M
YoY Change -7.93%
TOTAL ASSETS
Total Short-Term Assets $289.7K
Total Long-Term Assets $1.055M
Total Assets $1.345M
YoY Change -48.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $252.5K
YoY Change -19.71%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $1.486M
YoY Change
Total Short-Term Liabilities $1.599M
YoY Change 408.38%
LONG-TERM LIABILITIES
Long-Term Debt $389.5K
YoY Change -73.09%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $389.5K
YoY Change -73.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.599M
Total Long-Term Liabilities $389.5K
Total Liabilities $1.988M
YoY Change 12.84%
SHAREHOLDERS EQUITY
Retained Earnings -$19.51M
YoY Change 12.61%
Common Stock $67.35K
YoY Change 18.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$643.0K
YoY Change
Total Liabilities & Shareholders Equity $1.345M
YoY Change -48.81%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$334.2K
YoY Change -29.53%
Depreciation, Depletion And Amortization $24.61K
YoY Change 6.81%
Cash From Operating Activities -$312.5K
YoY Change -26.04%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 201.8K
YoY Change -780.67%
NET CHANGE
Cash From Operating Activities -312.5K
Cash From Investing Activities 0.000
Cash From Financing Activities 201.8K
Net Change In Cash -110.6K
YoY Change -77.58%
FREE CASH FLOW
Cash From Operating Activities -$312.5K
Capital Expenditures $0.00
Free Cash Flow -$312.5K
YoY Change -32.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Assets
Assets
1345128 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54697
dei Entity Registrant Name
EntityRegistrantName
THE CORETEC GROUP INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OK
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
652990 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
52849 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-334224 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-642951 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-474295 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
865978 usd
us-gaap Depreciation
Depreciation
4746 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
41314 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
41315 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5726 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
32532 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 us-gaap Cash
Cash
4437 usd
CY2023Q4 us-gaap Cash
Cash
523988 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
35264 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
252462 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
75918 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1598537 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
647369 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.06
dei Document Type
DocumentType
10-Q
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
132680 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
289701 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101846 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
783031 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
824345 usd
CY2024Q2 us-gaap Goodwill
Goodwill
166000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
166000 usd
CY2024Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
4550 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
4550 usd
CY2024Q2 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
953581 usd
CY2023Q4 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
994895 usd
CY2023Q4 us-gaap Assets
Assets
1761329 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1346075 usd
CY2024Q2 us-gaap Liabilities
Liabilities
1988079 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
69 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
336738361
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
284104032
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
67346 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18801033 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19511399 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-642951 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1345128 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
182254 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
233348 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
592852 usd
us-gaap Interest Expense
InterestExpense
84299 usd
us-gaap Interest Expense
InterestExpense
106929 usd
us-gaap Costs And Expenses
CostsAndExpenses
859405 usd
us-gaap Costs And Expenses
CostsAndExpenses
993267 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
958 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
11588 usd
us-gaap Net Income Loss
NetIncomeLoss
-858447 usd
us-gaap Net Income Loss
NetIncomeLoss
-981679 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.004
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
272378123
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
59801 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
121445 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
234753 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
305796 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
39781 usd
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
334335 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
480090 usd
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
111 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
5795 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-334224 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-474295 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.002
dei Entity Address Address Line1
EntityAddressAddressLine1
333 Jackson Plaza, STE 460
dei Entity Address City Or Town
EntityAddressCityOrTown
Ann Arbor
dei Entity Address State Or Province
EntityAddressStateOrProvince
MI
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
48103
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.003
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
317074335
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
73-1479206
dei Local Phone Number
LocalPhoneNumber
916-0833
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
336738361
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001375195
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
dei City Area Code
CityAreaCode
866
CY2024Q2 crtg Deposit Prepaid Warrant Purchase
DepositPrepaidWarrantPurchase
250000 usd
CY2023Q4 crtg Deposit Prepaid Warrant Purchase
DepositPrepaidWarrantPurchase
0 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
656668 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
109766 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
571451 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1651185 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
69 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
336738361
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
284104032
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
56819 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18706208 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18652952 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
110144 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1761329 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
275885045
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
304971806
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
110144 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8960 usd
CY2024Q1 crtg Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
0 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-524223 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-405119 usd
CY2024Q2 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
96392 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1828320 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-507384 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1320936 usd
CY2023Q2 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
18087 usd
CY2023Q2 crtg Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1250 usd
us-gaap Net Income Loss
NetIncomeLoss
-858447 usd
us-gaap Net Income Loss
NetIncomeLoss
-981679 usd
us-gaap Depreciation
Depreciation
7920 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-97416 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-82722 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
250000 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
281896 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
15531 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-674175 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-804833 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41374 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
95376 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
61398 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1250 usd
crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
250000 usd
crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
154624 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-60148 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-519551 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-906355 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
523988 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2356348 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4437 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1449993 usd
us-gaap Interest Paid Net
InterestPaidNet
2320 usd
us-gaap Interest Paid Net
InterestPaidNet
68359 usd
crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
105352 usd
crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
18087 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.</p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
312867697
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
242442697
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
628976 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
587662 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
783031 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
824345 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25345 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17425 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101846 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
109766 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1485617 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
476075 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
389542 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1003816 usd
crtg Amortization Associated With Commitment Fee
AmortizationAssociatedWithCommitmentFee
1688 usd
crtg Amortization Associated With Commitment Fee
AmortizationAssociatedWithCommitmentFee
8674 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
476075 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
870000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
139542 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
1485617 usd
CY2020Q2 crtg Share Exchange Agreement Number Of Options Authorized
ShareExchangeAgreementNumberOfOptionsAuthorized
21500000
CY2020Q2 crtg Share Exchange Agreement Exchange Ratio
ShareExchangeAgreementExchangeRatio
0.6 rate
crtg Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged
9500000
crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
5700000
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2814000
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
120014000
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0612
CY2023 crtg Class Of Warrant Or Right Contractual Term
ClassOfWarrantOrRightContractualTerm
P2Y7M17D
crtg Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
28700000
crtg Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
0.0001
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
91314000
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0805
crtg Class Of Warrant Or Right Contractual Term
ClassOfWarrantOrRightContractualTerm
P2Y1M9D
CY2024Q2 crtg Class Of Warrant Or Right Intrinsic Value
ClassOfWarrantOrRightIntrinsicValue
0 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
101158160
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.059
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3000000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.024
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
98158160
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y8M1D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
98158160
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.06
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y8M1D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2024Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
98158160
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P2Y8M1D
CY2024Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
98158160
us-gaap Operating Lease Expense
OperatingLeaseExpense
28100 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
27300 usd
CY2024Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
13500 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
13650 usd

Files In Submission

Name View Source Status
0001437749-24-026718-index-headers.html Edgar Link pending
0001437749-24-026718-index.html Edgar Link pending
0001437749-24-026718.txt Edgar Link pending
0001437749-24-026718-xbrl.zip Edgar Link pending
crtg-20240630.xsd Edgar Link pending
crtg20240630_10q.htm Edgar Link pending
crtg20240630_10qimg012.jpg Edgar Link pending
ex_712176.htm Edgar Link pending
ex_712177.htm Edgar Link pending
ex_714783.htm Edgar Link pending
ex_714784.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
crtg-20240630_cal.xml Edgar Link unprocessable
crtg-20240630_def.xml Edgar Link unprocessable
crtg-20240630_lab.xml Edgar Link unprocessable
crtg-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
crtg20240630_10q_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending